跳至主要内容
临床试验/JPRN-UMIN000017397
JPRN-UMIN000017397已完成1 期

Hepatic Resection for Colorectal Liver Metastases following Panitumumab(Vectibix) with Chemotherapy Cohort study - Hepatic Resection for Colorectal Liver Metastases following Panitumumab(Vectibix) with Chemotherapy Cohort study

Gastroenterological Surgery1, Hokkaido University Graduate school of medicine0 个研究点目标入组 100 人开始时间: 2015年5月2日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.The cases with serious drug hyper reaction against panitumumab, fluorouracil folinic acid, oxaliplatin, irinotecan 2.The cases with serious hypersensitivity having functional disorder or sensory disturbance 3. The cases with bone marrow suppression or its history, systemic infection, interstitial pneumonia, diarrhea, ileus, a lot of ascites or hydrothorax, icterus 4.The cases with interstitial pneumonia or its history 5.The cases with serious complications -Poor control diabetes mellitus -Heart failure beyond NYHA3 -Renal failure -Liver failure 6.The cases with mutative or unjudged type about KRAS status 7.The cases without a history of chemotherapy 8.Pregnant or lactating women 9.The cases judged to be unsuitable for registration

研究者

发起方
Gastroenterological Surgery1, Hokkaido University Graduate school of medicine

相似试验